source
- Haisco Pharmaceutical partners with ARCH Venture Partners and Population Health in new China-focused dealHaisco Pharmaceutical, a China-based drugmaker, has continued its active summer dealmaking by striking a new partnership. The partnership brings together ARCH Venture Partners, a venture capital f…
- Haisco partners with US VCs to launch immunology biotech Sentivera with up to $1.5B fundingHaisco Pharmaceutical Group announced the creation of a new immunology-focused biotech called Sentivera, backed by two American venture‑capital firms, Population Health Partners and ARCH Venture Pa…